Vigil Neuroscience, Inc. – NASDAQ:VIGL
Vigil Neuroscience stock price today
$8.05
+6.4
+387.88%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 1 hour
Vigil Neuroscience stock price monthly change
-62.07%
month
Vigil Neuroscience stock price quarterly change
-62.07%
quarter
Vigil Neuroscience stock price yearly change
-54.55%
year
Vigil Neuroscience key metrics
Market Cap | 63.77M |
Enterprise value | 131.68M |
P/E | -4.5 |
EV/Sales | N/A |
EV/EBITDA | -1.30 |
Price/Sales | N/A |
Price/Book | 1.68 |
PEG ratio | -0.04 |
EPS | -2.12 |
Revenue | N/A |
EBITDA | -89.16M |
Income | -82.78M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeVigil Neuroscience stock price history
Vigil Neuroscience stock forecast
Vigil Neuroscience financial statements
| Jun 2023 | 0 | -20.17M | |
|---|---|---|---|
| Sep 2023 | 0 | -20.49M | |
| Dec 2023 | 1.93M | -22.17M | -1146.54% |
| Mar 2024 | 0 | -19.94M |
| Dec 2023 | 1.93M | -22.17M | -1146.54% |
|---|---|---|---|
| Mar 2024 | 0 | -19.94M | |
| Oct 2025 | 0 | -19.33M | |
| Dec 2025 | 0 | -19.93M |
Analysts Price target
Financials & Ratios estimates
| 2023-11-07 | -0.57 | -0.53 |
|---|---|---|
| 2024-03-26 | -0.56 | -0.57 |
| 2024-05-07 | -0.6 | -0.5 |
| Jun 2023 | 175409000 | 21.57M | 12.3% |
|---|---|---|---|
| Sep 2023 | 159156000 | 23.32M | 14.65% |
| Dec 2023 | 140858000 | 24.60M | 17.47% |
| Mar 2024 | 125078000 | 21.29M | 17.03% |
| Jun 2023 | -15.35M | -22.10M | 579K |
|---|---|---|---|
| Sep 2023 | -17.31M | 15.31M | 53K |
| Dec 2023 | -15.51M | 10.65M | 53K |
| Mar 2024 | -21.88M | 16.46M | 5.18M |
Vigil Neuroscience alternative data
| Aug 2023 | 59 |
|---|---|
| Sep 2023 | 61 |
| Oct 2023 | 61 |
| Nov 2023 | 61 |
| Dec 2023 | 66 |
| Jan 2024 | 66 |
| Feb 2024 | 66 |
| Mar 2024 | 69 |
| Apr 2024 | 69 |
| May 2024 | 69 |
| Jun 2024 | 65 |
| Jul 2024 | 65 |
Vigil Neuroscience other data
10.22%
-64.80%
of VIGL is owned by hedge funds
13
-23
3.23M
-21.74M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Dec 2024 | 27000 | 0 |
-
What's the price of Vigil Neuroscience stock today?
One share of Vigil Neuroscience stock can currently be purchased for approximately $8.05.
-
When is Vigil Neuroscience's next earnings date?
Unfortunately, Vigil Neuroscience's (VIGL) next earnings date is currently unknown.
-
Does Vigil Neuroscience pay dividends?
No, Vigil Neuroscience does not pay dividends.
-
How much money does Vigil Neuroscience make?
Vigil Neuroscience has a market capitalization of 63.77M. Vigil Neuroscience made a loss 82.64M US dollars in net income (profit) last year or -$0.5 on an earnings per share basis.
-
What is Vigil Neuroscience's stock symbol?
Vigil Neuroscience, Inc. is traded on the NASDAQ under the ticker symbol "VIGL".
-
What is Vigil Neuroscience's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Vigil Neuroscience?
Shares of Vigil Neuroscience can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Vigil Neuroscience have?
As Jul 2024, Vigil Neuroscience employs 65 workers, which is 6% less then previous quarter.
-
When Vigil Neuroscience went public?
Vigil Neuroscience, Inc. is publicly traded company for more then 3 years since IPO on 7 Jan 2022.
-
What is Vigil Neuroscience's official website?
The official website for Vigil Neuroscience is vigilneuro.com.
-
Where are Vigil Neuroscience's headquarters?
Vigil Neuroscience is headquartered at 1 Broadway, Cambridge, MA.
-
How can i contact Vigil Neuroscience?
Vigil Neuroscience's mailing address is 1 Broadway, Cambridge, MA and company can be reached via phone at 857 254 4445.
Vigil Neuroscience company profile:
Vigil Neuroscience, Inc.
vigilneuro.comExchange:
NASDAQ
Full time employees:
64
Industry:
Biotechnology
Sector:
Healthcare
Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed on myeloid cells 2 (TREM2) which is in Phase I for the treatment of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia, as well as for the treatment of cerebral adrenoleukodystrophy and alzheimer's disease. The company also develops a small molecule TREM2 agonist suitable for oral delivery to treat common neurodegenerative diseases associated with microglial dysfunction. Vigil Neuroscience, Inc. was incorporated in 2020 and is headquartered in Cambridge, Massachusetts.
1 Broadway
Cambridge, MA 02142
Cambridge, MA 02142
CIK: 0001827087
ISIN: US92673K1088
CUSIP: 92673K108
